IIFL Capital Announces Tendering Period Start for Indo Borax Open Offer at ₹256.30
IIFL Capital Services Limited has announced the commencement of the tendering period on April 10, 2026, for Zenrock Chemicals' open offer to acquire 83,43,400 equity shares (26% stake) in Indo Borax & Chemicals at ₹256.30 per share. The Independent Directors Committee has recommended the offer as fair and reasonable, while the underlying transaction involving 50.80% stake acquisition was completed on January 23, 2026.

*this image is generated using AI for illustrative purposes only.
Indo Borax & Chemicals Limited's open offer has reached a significant milestone with IIFL Capital Services Limited announcing the commencement of the tendering period on April 10, 2026. The Independent Directors Committee has already recommended the open offer price of ₹256.30 per equity share as fair and reasonable under applicable SEBI regulations.
Open Offer Structure and Timeline
The open offer by Zenrock Chemicals Private Limited and its persons acting in concert targets the acquisition of up to 83,43,400 fully paid-up equity shares representing 26.00% of the voting share capital from public shareholders. IIFL Capital Services Limited, acting as the manager to the offer, has published the offer opening public announcement in Financial Express, Jansatta, and Navshakti newspapers.
| Key Timeline: | Date |
|---|---|
| Tendering Period Commencement: | April 10, 2026 |
| Tendering Period Closure: | April 24, 2026 |
| Payment Completion: | May 11, 2026 |
| Post-Offer Announcement: | May 18, 2026 |
Independent Directors Committee Assessment
The IDC meeting held on April 6, 2026, with all three members present—Prasad Parameswaranpillai Naga (Chairperson), Prajnaparamita Sarkar, and Rakesh Kumar Shrivastava—unanimously approved the recommendation. The committee's assessment was based on comprehensive regulatory compliance and market comparison criteria.
| Assessment Parameters: | Details |
|---|---|
| Offer Price: | ₹256.30 per equity share |
| 60-day VWAP on NSE: | ₹253.23 per equity share |
| Regulatory Compliance: | Aligned with SEBI (SAST) Regulation 8(2) |
| Share Trading Status: | Frequently traded securities |
Completed Underlying Transaction
The underlying transaction has been successfully completed on January 23, 2026, with the acquirer and persons acting in concert acquiring 1,63,00,230 equity shares representing 50.80% of the total paid-up equity share capital. Zenrock Chemicals acquired 98,82,230 shares (30.80%), while the three PACs acquired varying percentages totaling 20.00%.
| Entity: | Shares Acquired | Percentage |
|---|---|---|
| Zenrock Chemicals: | 98,82,230 shares | 30.80% |
| India Special Assets Fund III: | 23,87,496 shares | 7.44% |
| ISAF III Onshore Fund: | 24,26,004 shares | 7.56% |
| Special Situation India Fund: | 16,04,500 shares | 5.00% |
Tendering Process and Documentation
Public shareholders can participate through the stock exchange mechanism via BSE and NSE acquisition windows. The Letter of Offer dated March 27, 2026, has been dispatched to shareholders as of the identified date (March 24, 2026). Shareholders holding dematerialized shares must approach their selling brokers, while physical share holders need to submit original certificates along with required documentation to the registrar.
The offer maintains regulatory compliance with no competing offers received by the deadline. All statutory approvals are in place, and the PACs have confirmed they do not intend to exercise control over the target company's management decisions.
Source: Company/INE803D01021/17ec4b0a-f91e-445f-8808-3f71a59925d2.pdf
Historical Stock Returns for Indo Borax & Chemicals
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| +13.93% | +10.45% | +15.21% | +4.41% | +56.03% | +90.06% |
How will Zenrock Chemicals' majority control impact Indo Borax's strategic direction and operational decisions despite their stated intention not to exercise management control?
What are the potential synergies between Zenrock Chemicals and Indo Borax that could drive value creation post-acquisition?
Will the successful completion of this open offer trigger similar consolidation activities in the specialty chemicals sector?


































